Phenolic Acids as Antidepressant Agents.

Area of Science:

• Neuroscience and Pharmacology
• Phytochemistry and Medicinal Plants

Background:

• Depression is a global psychiatric disorder with complex pathophysiology and poorly understood molecular pathways.
• Current pharmacological treatments for depression can be ineffective or cause adverse side effects.
• There is a need for alternative therapeutic strategies to manage depressive symptoms.

Purpose of the Study:

• To review the effects of phenolic acids and medicinal plant extracts on depressive symptoms.
• To explore the molecular interactions and pathways involved in these effects.
• To assess the potential of phytochemicals as alternative depression treatments.

Main Methods:

• Review of preclinical trials and scientific literature on phenolic acids and medicinal plants.
• Analysis of studies investigating molecular mechanisms, including oxidative stress, neuroinflammation, and neurotransmission.
• Focus on animal models to evaluate depressive-like behaviors and therapeutic potential.

Main Results:

• Phenolic acids demonstrate potential in reducing depressive-like behaviors in preclinical studies.
• These compounds modulate key factors including oxidative stress, neuroinflammation, and the hypothalamic-pituitary-adrenal axis.
• Evidence suggests stimulation of monoaminergic neurotransmission, neurogenesis, and modulation of gut microbiota contribute to the antidepressant effects.

Conclusions:

• Phenolic acids derived from medicinal plants represent a promising avenue for novel depression therapies.
• Their antioxidant and anti-inflammatory properties underpin their efficacy in addressing depression's molecular underpinnings.
• Further research into these phytochemicals could lead to safer and more effective depression management strategies.